Advanced Biomed Inc Increase (Decrease) in Accounts Payable and Other Operating Liabilities
Advanced Biomed Inc (ADVB) reported Increase (Decrease) in Accounts Payable and Other Operating Liabilities of -$291.73 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities · last filed 2026-05-15
- Advanced Biomed Inc increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2026-03-31 was $40.34K.
- Advanced Biomed Inc increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2025-12-31 was -$99.50K.
- Advanced Biomed Inc increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2025-09-30 was -$232.57K, a 233.85% decline year-over-year.
- Advanced Biomed Inc increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2025-06-30 was $2.06M, a 1016.43% increase year-over-year.
- Advanced Biomed Inc increase (decrease) in accounts payable and other operating liabilities for fiscal 2025 was -$117.66K, a 124.53% decline from fiscal 2024.
- Advanced Biomed Inc increase (decrease) in accounts payable and other operating liabilities for fiscal 2024 was $479.63K.
| Period end | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 3 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 6 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 9 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2026-03-31 | $40.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | -$59.15K derived: sum of 2 quarters · filed 2026-05-15 | -$291.73K 10-Q · filed 2026-05-15 | $1.76M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-12-31 | -$99.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | -$332.07K 10-Q · filed 2026-02-13 | $1.72M derived: sum of 3 quarters · filed 2026-02-13 | -$490.78K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-09-30 | -$232.57K 10-Q · filed 2025-11-19 | $1.82M derived: sum of 2 quarters · filed 2025-11-19 | -$391.28K derived: sum of 3 quarters · filed 2026-05-15 | -$523.99K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-06-30 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | -$158.71K derived: sum of 2 quarters · filed 2026-05-15 | -$291.41K derived: sum of 3 quarters · filed 2026-05-15 | -$117.66K 10-K · filed 2025-10-08 | ||
| 2025-03-31 | -$2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | -$2.35M derived: sum of 2 quarters · filed 2026-05-15 | -$2.17M 10-Q · filed 2026-05-15 | $98.77K 10-Q · filed 2025-05-15 | -$1.99M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$132.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | $41.05K 10-Q · filed 2026-02-13 | $90.43K 10-Q · filed 2025-04-15 | $225.13K derived: sum of 3 quarters · filed 2026-02-13 | $142.67K derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-09-30 | $173.75K 10-Q · filed 2025-11-19 | $357.84K derived: sum of 2 quarters · filed 2025-11-19 | $275.37K derived: sum of 3 quarters · filed 2025-11-19 | |||
| 2024-06-30 | $184.09K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | $101.62K derived: sum of 2 quarters · filed 2025-10-08 | $479.63K 10-K · filed 2025-10-08 | |||
| 2024-03-31 | -$82.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | $295.55K 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | $378.01K 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |